drugset / Trial / NCT05540431

Evaluation of Protective Effect of Activated Charcoal and Probiotic Against Progression of Chronic Kidney Disease

NCT05540431

Phase 2/3 Unknown 60 enrolled Waleed Khaild Rahman Kareem Al-kabi
RandomizedParallel-groupOpen-labelPrevention

Summary

Investigate the nephroprotective effect of Activated Charcoal and Probiotic in limiting the progression of renal impairment in patients with chronic kidney disease and improving of renal function test and phosphate level. Condition or disease: chronic kidney disease

Timeline

Start
2022-09-25
Primary completion
2023-09-20
Completion
2023-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Activated Charcoal Other / unclassified Oral

Indications